Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01309568 · ClinicalTrials.gov registry record
"Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"
A clinical trial, sponsored by Quidel Corporation.
- Completed
- Registry status
- 2,500
- Enrollment target
NCT01309568 is a clinical trial that has completed, run by Quidel Corporation. The registered enrollment target is 2,500 participants.
The verdict
NCT01309568 has completed, sponsored by Quidel Corporation.
- COMPLETED
- Registry status
- 2,500 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate the clinical performance of the Quidel Reader Influenza A+B test and Quidel Reader with the following sample types: nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/wash. Clinical performance will be based on comparison of Quidel Reader Influenza A+B results to cell culture at a Central Reference or Alternative Laboratory.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01309568
The ClinicalTrials.gov registry entry for NCT01309568 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Quidel Corporation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01309568 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01309568 about?
NCT01309568 is a clinical study titled ""Quidel Reader Influenza A + B Test 510(k) and CLIA Waiver Field Study"". The objective of this study is to demonstrate the clinical performance of the Quidel Reader Influenza A+B test and Quidel Reader with the following sample types: nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/wash. Clinical performance will be based on comparison of Quidel Reader Influ...
What is the current status of trial NCT01309568?
This trial is currently completed. The enrollment target is 2,500 participants. The study started on 2011-02. Estimated completion is 2011-04.
Who is sponsoring clinical trial NCT01309568?
This trial is sponsored by Quidel Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.